Biodexa Pharmaceuticals Plc ADR (BDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 06-2025 | 12-2024 | 06-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,419 | -5,083 | -7,321 | -4,175 | -8,806 |
| Depreciation Amortization | 249 | 187 | 325 | 172 | 352 |
| Accounts receivable | N/A | 2,734 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | -2,791 | N/A | N/A | N/A |
| Other Working Capital | 2,263 | -57 | -4,774 | -1,101 | -61 |
| Other Operating Activity | -1,466 | 598 | -3,898 | -963 | 24 |
| Operating Cash Flow | $-7,373 | $-4,413 | $-15,668 | $-6,067 | $-8,491 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 21 | -3 | -12 | N/A | -27 |
| Purchase Sale Intangibles | N/A | -497 | N/A | N/A | N/A |
| Other Investing Activity | -790 | -450 | -753 | -952 | -303 |
| Investing Cash Flow | $-769 | $-453 | $-764 | $-952 | $-330 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -182 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 8,349 | N/A | N/A | N/A |
| Other Financing Activity | 17,195 | -140 | 10,935 | 5,862 | 12,720 |
| Financing Cash Flow | $17,195 | $8,027 | $10,935 | $5,862 | $12,720 |
| Beginning Cash Position | 2,201 | 2,229 | 7,630 | 7,536 | 3,528 |
| End Cash Position | 11,254 | 5,391 | 2,133 | 6,380 | 7,427 |
| Net Cash Flow | $9,053 | $3,161 | $-5,498 | $-1,156 | $3,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,373 | -4,413 | -15,668 | -6,067 | -8,491 |
| Capital Expenditure | N/A | -3 | N/A | N/A | N/A |
| Free Cash Flow | -7,373 | -4,416 | -15,668 | -6,067 | -8,491 |